Even though Medicare spends over $1 billion per year on breast cancer screenings such as a mammography, there is no evidence that higher spending benefits older women, researchers at Yale School of Medicine found in a study ...
Jan 7, 2013
0
0
A new multiple gene expression profile test was able to predict the presence of harmful BRCA1 or BRCA2 mutations in otherwise healthy women carrying the mutations, according to data published in Cancer Prevention Research, ...
Jan 22, 2013
0
0
There is an enormous amount that we do not understand about the fundamental causes and behavior of cancer cells, but at some level, experts believe that cancer must relate to DNA and the genome.
Jun 7, 2017
0
0
The majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with immune checkpoint inhibitors (ICIs) had no disease progression two years after discontinuing treatment, ...
Dec 18, 2023
0
2
A systemic review of the current body of research shows that investigators have inadequately addressed the intersection of aging, health disparities, and cancer outcomes among older adults. This is the conclusion of a paper ...
Apr 19, 2024
0
19
A group of molecular markers have been identified that can help clinicians determine which patients with low-grade oral premalignant lesions are at high risk for progression to oral cancer, according to data from the Oral ...
Aug 21, 2012
0
0
Twenty-nine percent of patients with colorectal cancer in a nationally representative sample were diagnosed after an emergency, such as an obstruction or perforation of the bowel, according to data presented at the 11th Annual ...
Oct 17, 2012
0
0
(HealthDay)—Doctors believe they have found telltale signs that can indicate whether breast or prostate malignancies will remain dormant or develop into aggressive cancers.
Oct 28, 2013
0
0
A Wayne State University researcher has identified characteristics in benign breast disease associated with future cancer risk in African-American women.
Feb 11, 2013
0
0
A new analysis has provided a comprehensive comparison of scores designed to predict which women with oestrogen-receptor positive breast cancer are at high risk of recurrence beyond five years after diagnosis, and may benefit ...
May 2, 2013
0
0
